{"id":"https://openalex.org/W1933265282","doi":"https://doi.org/10.1002/hon.2136","title":"Biweekly THP\u2010COP therapy for newly diagnosed peripheral T\u2010cell lymphoma patients","display_name":"Biweekly THP\u2010COP therapy for newly diagnosed peripheral T\u2010cell lymphoma patients","publication_year":2014,"publication_date":"2014-02-11","ids":{"openalex":"https://openalex.org/W1933265282","doi":"https://doi.org/10.1002/hon.2136","mag":"1933265282","pmid":"https://pubmed.ncbi.nlm.nih.gov/24519501"},"language":"en","primary_location":{"id":"doi:10.1002/hon.2136","doi":"https://doi.org/10.1002/hon.2136","is_oa":false,"landing_page_url":"https://doi.org/10.1002/hon.2136","pdf_url":null,"source":{"id":"https://openalex.org/S23714410","display_name":"Hematological Oncology","issn_l":"0278-0232","issn":["0278-0232","1099-1069"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematological Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034618139","display_name":"Naoto Tomita","orcid":"https://orcid.org/0000-0002-5441-1177","observed_orcids":["https://orcid.org/0000-0002-5441-1177"]},"institutions":[{"id":"https://openalex.org/I89630735","display_name":"Yokohama City University","ror":"https://ror.org/0135d1r83","country_code":"JP","type":"education","lineage":["https://openalex.org/I89630735"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Naoto Tomita","raw_affiliation_strings":["Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan","institution_ids":["https://openalex.org/I89630735"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108357955","display_name":"Fumio Kodama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152949","display_name":"Kanagawa Cancer Center","ror":"https://ror.org/00aapa202","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4387152949"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Fumio Kodama","raw_affiliation_strings":["Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan","institution_ids":["https://openalex.org/I4387152949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024418836","display_name":"Naoko Tsuyama","orcid":"https://orcid.org/0000-0002-8718-4599","observed_orcids":["https://orcid.org/0000-0002-8718-4599"]},"institutions":[{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoko Tsuyama","raw_affiliation_strings":["Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan","institution_ids":["https://openalex.org/I42570316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068180537","display_name":"Seiji Sakata","orcid":"https://orcid.org/0009-0005-2636-697X","observed_orcids":["https://orcid.org/0009-0005-2636-697X"]},"institutions":[{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Seiji Sakata","raw_affiliation_strings":["Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan","institution_ids":["https://openalex.org/I42570316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044544485","display_name":"Kengo Takeuchi","orcid":"https://orcid.org/0000-0002-1599-5800","observed_orcids":["https://orcid.org/0000-0002-1599-5800"]},"institutions":[{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kengo Takeuchi","raw_affiliation_strings":["Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan","Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan","institution_ids":["https://openalex.org/I42570316"]},{"raw_affiliation_string":"Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan","institution_ids":["https://openalex.org/I42570316"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Daisuke Ishibashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405253033","display_name":"Yokosuka City Hospital","ror":"https://ror.org/007wr0r46","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405253033"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Daisuke Ishibashi","raw_affiliation_strings":["Department of Hematology, Yokosuka City Hospital, Yokosuka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Yokosuka City Hospital, Yokosuka, Japan","institution_ids":["https://openalex.org/I4405253033"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101554289","display_name":"Satoshi Koyama","orcid":"https://orcid.org/0000-0002-3021-1250","observed_orcids":["https://orcid.org/0000-0002-3021-1250","https://orcid.org/0000-0002-9637-8440"]},"institutions":[{"id":"https://openalex.org/I4210134472","display_name":"Shizuoka Red Cross Hospital","ror":"https://ror.org/03j7khn53","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210134472"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satoshi Koyama","raw_affiliation_strings":["Department of Hematology, Shizuoka Red Cross Hospital, Shizuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Shizuoka Red Cross Hospital, Shizuoka, Japan","institution_ids":["https://openalex.org/I4210134472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074616675","display_name":"Yoshimi Ishii","orcid":"https://orcid.org/0000-0001-6194-6770","observed_orcids":["https://orcid.org/0000-0001-6194-6770"]},"institutions":[{"id":"https://openalex.org/I89630735","display_name":"Yokohama City University","ror":"https://ror.org/0135d1r83","country_code":"JP","type":"education","lineage":["https://openalex.org/I89630735"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshimi Ishii","raw_affiliation_strings":["Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan","institution_ids":["https://openalex.org/I89630735"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086225100","display_name":"Wataru Yamamoto","orcid":"https://orcid.org/0000-0002-0810-4221","observed_orcids":["https://orcid.org/0000-0002-0810-4221"]},"institutions":[{"id":"https://openalex.org/I4387152949","display_name":"Kanagawa Cancer Center","ror":"https://ror.org/00aapa202","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4387152949"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Wataru Yamamoto","raw_affiliation_strings":["Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan","institution_ids":["https://openalex.org/I4387152949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027783702","display_name":"Hirotaka Takasaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152949","display_name":"Kanagawa Cancer Center","ror":"https://ror.org/00aapa202","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4387152949"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hirotaka Takasaki","raw_affiliation_strings":["Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan","institution_ids":["https://openalex.org/I4387152949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046884055","display_name":"Maki Hagihara","orcid":"https://orcid.org/0000-0002-4928-2147","observed_orcids":["https://orcid.org/0000-0002-4928-2147"]},"institutions":[{"id":"https://openalex.org/I89630735","display_name":"Yokohama City University","ror":"https://ror.org/0135d1r83","country_code":"JP","type":"education","lineage":["https://openalex.org/I89630735"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Maki Hagihara","raw_affiliation_strings":["Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan","institution_ids":["https://openalex.org/I89630735"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000614616","display_name":"Hideyuki Kuwabara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802180866","display_name":"Yokohama City University Medical Center","ror":"https://ror.org/03k95ve17","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2802180866"]},{"id":"https://openalex.org/I4210099218","display_name":"Yokohama City University Hospital","ror":"https://ror.org/010hfy465","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210099218"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideyuki Kuwabara","raw_affiliation_strings":["Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan","institution_ids":["https://openalex.org/I2802180866","https://openalex.org/I4210099218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004509292","display_name":"Masatsugu Tanaka","orcid":"https://orcid.org/0000-0001-8814-230X","observed_orcids":["https://orcid.org/0000-0001-8814-230X"]},"institutions":[{"id":"https://openalex.org/I2802180866","display_name":"Yokohama City University Medical Center","ror":"https://ror.org/03k95ve17","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2802180866"]},{"id":"https://openalex.org/I4210099218","display_name":"Yokohama City University Hospital","ror":"https://ror.org/010hfy465","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210099218"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masatsugu Tanaka","raw_affiliation_strings":["Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan","institution_ids":["https://openalex.org/I2802180866","https://openalex.org/I4210099218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003303822","display_name":"Chizuko Hashimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152949","display_name":"Kanagawa Cancer Center","ror":"https://ror.org/00aapa202","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4387152949"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Chizuko Hashimoto","raw_affiliation_strings":["Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan","institution_ids":["https://openalex.org/I4387152949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112176243","display_name":"Etsuko Yamazaki","orcid":"https://orcid.org/0000-0002-3808-4006","observed_orcids":["https://orcid.org/0000-0002-3808-4006"]},"institutions":[{"id":"https://openalex.org/I89630735","display_name":"Yokohama City University","ror":"https://ror.org/0135d1r83","country_code":"JP","type":"education","lineage":["https://openalex.org/I89630735"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Etsuko Yamazaki","raw_affiliation_strings":["Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan","institution_ids":["https://openalex.org/I89630735"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030305676","display_name":"Hideyuki Koharazawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151705","display_name":"Yamato Municipal Hospital","ror":"https://ror.org/045fvx862","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210151705"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideyuki Koharazawa","raw_affiliation_strings":["Department of Hematology, Yamato Municipal Hospital, Yamato, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Yamato Municipal Hospital, Yamato, Japan","institution_ids":["https://openalex.org/I4210151705"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082863122","display_name":"Katsumichi Fujimaki","orcid":"https://orcid.org/0000-0002-9996-6459","observed_orcids":["https://orcid.org/0000-0002-9996-6459"]},"institutions":[{"id":"https://openalex.org/I2799590887","display_name":"Fujisawa City Hospital","ror":"https://ror.org/04dd5bw95","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2799590887"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Katsumichi Fujimaki","raw_affiliation_strings":["Department of Hematology/Immunology, Fujisawa City Hospital, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology/Immunology, Fujisawa City Hospital, Fujisawa, Japan","institution_ids":["https://openalex.org/I2799590887"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102791309","display_name":"Rika Sakai","orcid":"https://orcid.org/0000-0002-5832-5268","observed_orcids":["https://orcid.org/0000-0002-5832-5268"]},"institutions":[{"id":"https://openalex.org/I4387152949","display_name":"Kanagawa Cancer Center","ror":"https://ror.org/00aapa202","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4387152949"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Rika Sakai","raw_affiliation_strings":["Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan","institution_ids":["https://openalex.org/I4387152949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032187275","display_name":"Shin Fujisawa","orcid":"https://orcid.org/0000-0003-2028-0209","observed_orcids":["https://orcid.org/0000-0003-2028-0209"]},"institutions":[{"id":"https://openalex.org/I2802180866","display_name":"Yokohama City University Medical Center","ror":"https://ror.org/03k95ve17","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2802180866"]},{"id":"https://openalex.org/I4210099218","display_name":"Yokohama City University Hospital","ror":"https://ror.org/010hfy465","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210099218"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shin Fujisawa","raw_affiliation_strings":["Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan","institution_ids":["https://openalex.org/I2802180866","https://openalex.org/I4210099218"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031542442","display_name":"Yoshiaki Ishigatsubo","orcid":"https://orcid.org/0000-0002-2908-1452","observed_orcids":["https://orcid.org/0000-0002-2908-1452"]},"institutions":[{"id":"https://openalex.org/I89630735","display_name":"Yokohama City University","ror":"https://ror.org/0135d1r83","country_code":"JP","type":"education","lineage":["https://openalex.org/I89630735"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiaki Ishigatsubo","raw_affiliation_strings":["Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan","institution_ids":["https://openalex.org/I89630735"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5034618139"],"corresponding_institution_ids":["https://openalex.org/I89630735"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":1.6376,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.84276261,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"33","issue":"1","first_page":"9","last_page":"14"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/peripheral-t-cell-lymphoma","display_name":"peripheral T-cell lymphoma","score":0.8809999823570251},{"id":"https://openalex.org/keywords/pirarubicin","display_name":"pirarubicin","score":0.796999990940094},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.828000009059906},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.968999981880188},{"id":"https://openalex.org/keywords/prednisolone","display_name":"prednisolone","score":0.8140000104904175},{"id":"https://openalex.org/keywords/biweekly-chemotherapy","display_name":"biweekly chemotherapy","score":0.8659999966621399},{"id":"https://openalex.org/keywords/newly-diagnosed-lymphoma","display_name":"newly diagnosed lymphoma","score":0.8550000190734863},{"id":"https://openalex.org/keywords/angioimmunoblastic-t-cell-lymphoma","display_name":"angioimmunoblastic T-cell lymphoma","score":0.9919999837875366},{"id":"https://openalex.org/keywords/doxorubicin-resistance","display_name":"doxorubicin resistance","score":0.8059999942779541},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7390000224113464},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7279999852180481},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.6499999761581421},{"id":"https://openalex.org/keywords/leukopenia","display_name":"leukopenia","score":0.8299999833106995}],"concepts":[{"id":"https://openalex.org/C2776085618","wikidata":"https://www.wikidata.org/wiki/Q3905585","display_name":"Pirarubicin","level":3,"score":0.9464846849441528},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8741453886032104},{"id":"https://openalex.org/C2909463153","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukocytopenia","level":3,"score":0.8455864191055298},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6558002233505249},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6398140788078308},{"id":"https://openalex.org/C2777891184","wikidata":"https://www.wikidata.org/wiki/Q7168693","display_name":"Peripheral T-cell lymphoma","level":4,"score":0.6373358964920044},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6112920045852661},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.6020209193229675},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.5987164378166199},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.580011248588562},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.4441056251525879},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.44172003865242004},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.41387802362442017},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1370575726032257},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.09725666046142578},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000505","descriptor_name":"Alopecia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007970","descriptor_name":"Leukopenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008231","descriptor_name":"Lymphopenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016411","descriptor_name":"Lymphoma, T-Cell, Peripheral","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/hon.2136","doi":"https://doi.org/10.1002/hon.2136","is_oa":false,"landing_page_url":"https://doi.org/10.1002/hon.2136","pdf_url":null,"source":{"id":"https://openalex.org/S23714410","display_name":"Hematological Oncology","issn_l":"0278-0232","issn":["0278-0232","1099-1069"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematological Oncology","raw_type":"journal-article"},{"id":"pmid:24519501","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24519501","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematological oncology","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W223760828","https://openalex.org/W1486772440","https://openalex.org/W1524390400","https://openalex.org/W1892527323","https://openalex.org/W1912693401","https://openalex.org/W1947696988","https://openalex.org/W1966255834","https://openalex.org/W1968394087","https://openalex.org/W1983084203","https://openalex.org/W1990670396","https://openalex.org/W1993637374","https://openalex.org/W1998175190","https://openalex.org/W2009086636","https://openalex.org/W2020055542","https://openalex.org/W2037284485","https://openalex.org/W2057897174","https://openalex.org/W2066391355","https://openalex.org/W2074643584","https://openalex.org/W2108465006","https://openalex.org/W2125847997","https://openalex.org/W2130410326","https://openalex.org/W2137905169","https://openalex.org/W2144933582","https://openalex.org/W2145164152","https://openalex.org/W2148781593","https://openalex.org/W2159285007","https://openalex.org/W2162389158","https://openalex.org/W2253853328","https://openalex.org/W2416844197"],"related_works":["https://openalex.org/W3046486227","https://openalex.org/W2563196346","https://openalex.org/W1921124690","https://openalex.org/W2949732854","https://openalex.org/W2329423868","https://openalex.org/W4410846020","https://openalex.org/W2988041406","https://openalex.org/W3156207978","https://openalex.org/W2097787459","https://openalex.org/W1999079839"],"abstract_inverted_index":{"Pirarubicin":[0],"tetrahydropyranyl":[1],"adriamycin":[2],"(THP-ADR)":[3],"is":[4,195,209],"an":[5],"analogue":[6],"of":[7,24,67,87,103,120,141,183],"doxorubicin.":[8],"This":[9,207],"agent":[10],"exhibits":[11],"activity":[12],"against":[13],"some":[14],"doxorubicin-resistant":[15],"cell":[16],"lines.":[17],"We":[18],"performed":[19],"a":[20,117,196,212],"phase":[21],"II":[22],"study":[23,208],"biweekly":[25,104,165],"THP-COP":[26,166,194],"[50":[27],"mg/m(2)":[28,31,34],"pirarubicin,":[29],"750":[30],"cyclophosphamide,":[32],"1.4":[33],"vincristine":[35],"(2.0":[36],"mg":[37],"maximum)":[38],"on":[39,46],"day":[40],"1,":[41],"and":[42,112,149,155,172,179,188,198],"100":[43],"mg/body":[44],"predonisolone":[45],"days":[47],"1-5]":[48],"in":[49,127,211],"patients":[50,57,99,129,190,202],"with":[51,58,116,138,164,203],"peripheral":[52],"T-cell":[53,77],"lymphoma":[54,78],"(PTCL).":[55],"Seventeen":[56],"newly":[59,204],"diagnosed":[60,205],"PTCL":[61],"were":[62,66,92,153,167],"enrolled.":[63],"Histological":[64],"diagnoses":[65],"PTCL,":[68],"not":[69],"otherwise":[70],"specified":[71],"(n":[72,79],"=":[73,80],"5),":[74],"or":[75],"angioimmunoblastic":[76],"12).":[81],"All":[82,98,182],"diagnostic":[83],"specimens":[84],"including":[85],"those":[86],"the":[88,189],"historical":[89],"control":[90],"group":[91,108],"centrally":[93],"reviewed":[94],"by":[95,176],"hematological":[96],"pathologists.":[97],"received":[100],"six":[101],"cycles":[102],"THP-COP.":[105],"The":[106,123,145,158],"patient":[107],"included":[109],"13":[110],"male":[111],"4":[113],"female":[114],"patients,":[115],"median":[118,124],"age":[119],"62":[121],"years.":[122],"follow-up":[125],"time":[126],"surviving":[128],"was":[130,136],"30":[131],"months.":[132],"Overall":[133],"response":[134],"rate":[135],"94%":[137],"15":[139],"cases":[140],"complete":[142],"remission":[143],"(88%).":[144,181],"3-year":[146],"progression-free":[147],"survival":[148,151],"overall":[150],"rates":[152],"57%":[154],"75%,":[156],"respectively.":[157],"most":[159],"frequent":[160],"adverse":[161],"events":[162],"associated":[163],"leukocytopenia":[168],"(100%),":[169,171,174],"neutropenia":[170],"lymphopenia":[173],"followed":[175],"alopecia":[177],"(92%)":[178],"anaemia":[180],"these":[184],"occurred":[185],"only":[186],"transiently,":[187],"subsequently":[191],"recovered.":[192],"Biweekly":[193],"safe":[197],"promising":[199],"therapy":[200],"for":[201],"PTCL.":[206],"registered":[210],"public":[213],"database":[214],"(UMIN000010485).":[215]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}